101 related articles for article (PubMed ID: 7636878)
1. Synthesis and biological evaluation of radioiodinated phospholipid ether stereoisomers.
Rampy MA; Pinchuk AN; Weichert JP; Skinner RW; Fisher SJ; Wahl RL; Gross MD; Counsell RE
J Med Chem; 1995 Aug; 38(16):3156-62. PubMed ID: 7636878
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of radioiodinated phospholipid ether analogs.
Rampy MA; Chou TS; Pinchuk AN; Skinner RW; Gross MD; Fisher S; Wahl R; Counsell RE
Nucl Med Biol; 1995 May; 22(4):505-12. PubMed ID: 7550028
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution, metabolism, and excretion of radioiodinated phospholipid ether analogs in tumor-bearing rats.
Plotzke KP; Rampy MA; Meyer K; Ruyan M; Fisher SJ; Wahl RL; Skinner RW; Gross MD; Counsell RE
J Nucl Biol Med (1991); 1993 Dec; 37(4):264-72. PubMed ID: 8172971
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship effects on the tumor avidity of radioiodinated phospholipid ether analogues.
Pinchuk AN; Rampy MA; Longino MA; Skinner RW; Gross MD; Weichert JP; Counsell RE
J Med Chem; 2006 Apr; 49(7):2155-65. PubMed ID: 16570911
[TBL] [Abstract][Full Text] [Related]
5. Potential tumor or organ-imaging agents. 30. Radioiodinated phospholipid ethers.
Meyer KL; Schwendner SW; Counsell RE
J Med Chem; 1989 Sep; 32(9):2142-7. PubMed ID: 2769685
[TBL] [Abstract][Full Text] [Related]
6. Selective localization of radioiodinated alkylphosphocholine derivatives in tumors.
Plotzke KP; Haradahira T; Stancato L; Olken NM; Skinner S; Gross MD; Wahl RL; Counsell RE
Int J Rad Appl Instrum B; 1992 Oct; 19(7):765-73. PubMed ID: 1399698
[TBL] [Abstract][Full Text] [Related]
7. Tumor visualization with a radioiodinated phospholipid ether.
Counsell RE; Schwendner SW; Meyer KL; Haradahira T; Gross MD
J Nucl Med; 1990 Mar; 31(3):332-6. PubMed ID: 2308004
[TBL] [Abstract][Full Text] [Related]
8. Biological disposition and imaging of a radioiodinated alkylphosphocholine in two rodent models of breast cancer.
Rampy MA; Brown RS; Pinchuk AN; Weichert JP; Skinner RW; Fisher SJ; Wahl RL; Gross MD; Ethier SP; Counsell RE
J Nucl Med; 1996 Sep; 37(9):1540-5. PubMed ID: 8790215
[TBL] [Abstract][Full Text] [Related]
9. Syntheses of racemic and nearly optically pure ether lipids and evaluation of in vitro antineoplastic activities.
Duclos RI; Chia HH; Abdelmageed OH; Esber H; Fournier DJ; Makriyannis A
J Med Chem; 1994 Nov; 37(24):4147-54. PubMed ID: 7990114
[TBL] [Abstract][Full Text] [Related]
10. Effect of temperature on the stereoselectivity of phospholipase D toward glycerol in the transphosphatidylation of phosphatidylcholine to phosphatidylglycerol.
Sato R; Itabashi Y; Suzuki A; Hatanaka T; Kuksis A
Lipids; 2004 Oct; 39(10):1019-23. PubMed ID: 15691025
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric in vitro synthesis of diastereomeric phosphatidylglycerols from phosphatidylcholine and glycerol by bacterial phospholipase D.
Sato R; Itabashi Y; Hatanaka T; Kuksis A
Lipids; 2004 Oct; 39(10):1013-8. PubMed ID: 15691024
[TBL] [Abstract][Full Text] [Related]
12. Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
Magistrelli A; Villa P; Benfenati E; Modest EJ; Salmona M; Tacconi MT
Drug Metab Dispos; 1995 Jan; 23(1):113-8. PubMed ID: 7720513
[TBL] [Abstract][Full Text] [Related]
13. Biologically active ether lipids. Biotransformation of rac-1(3)-O-alkylglycerols in cell suspension cultures of rape and semisynthesis of 1-O-alkyl-2-palmitoyl-sn-glycero-3-phospho-(N-palmitoyl)ethanolamines, potent antitumor agents.
Apte SS; Weber N; Mangold HK
FEBS Lett; 1990 Jun; 265(1-2):104-6. PubMed ID: 2365047
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
[TBL] [Abstract][Full Text] [Related]
15. Lack of enantio-selectivity in the in vitro antitumour cytotoxicity and membrane-damaging activity of ether lipid SRI 62-834: further evidence for a non-receptor-mediated mechanism of action.
Lohmeyer M; Workman P
Biochem Pharmacol; 1992 Aug; 44(4):819-23. PubMed ID: 1510728
[TBL] [Abstract][Full Text] [Related]
16. Determination of the substrate specificity of the phospholipase D from Streptomyces chromofuscus via an inorganic phosphate quantitation assay.
Martin SF; DeBlanc RL; Hergenrother PJ
Anal Biochem; 2000 Feb; 278(2):106-10. PubMed ID: 10660451
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell kinetics following antineoplastic ether phospholipid treatment.
Principe P; Sidoti C; Braquet P
Cancer Res; 1992 May; 52(9):2509-15. PubMed ID: 1568220
[TBL] [Abstract][Full Text] [Related]
18. Alkyl lysophospholipids inhibit phorbol ester-stimulated phospholipase D activity and DNA synthesis in fibroblasts.
Kiss Z; Crilly KS
FEBS Lett; 1997 Jul; 412(2):313-7. PubMed ID: 9256242
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of ether phospholipids and analogs in neoplastic cells.
Fleer EA; Unger C; Kim DJ; Eibl H
Lipids; 1987 Nov; 22(11):856-61. PubMed ID: 3444378
[TBL] [Abstract][Full Text] [Related]
20. Selective localization of a radioiodinated phospholipid ether analog in human tumor xenografts.
Plotzke KP; Fisher SJ; Wahl RL; Olken NM; Skinner S; Gross MD; Counsell RE
J Nucl Med; 1993 May; 34(5):787-92. PubMed ID: 8386759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
